Admaius Capital, an Africa-focused private equity investor operating across several growth markets, completed a minority investment in Parkville Pharmaceutical, a healthcare and wellness company in Egypt operating across several high-growth sub-segments. Financial terms were not disclosed. Admaius’ support will enable Parkville Pharmaceutical to expand regionally, leveraging its existing brands, strong pipeline, and Admaius’ extensive network. Enabling Parkville’s continued growth aligns with Admaius’ investment strategy for Africa of finding opportunities in high-impact sectors that are the drivers of economic and social progress, including digital infrastructure, financial services, FMCG, healthcare, and education.